SYMBIOSIS performs analytical services for recombinant proteins, antibodies and virus-like particles in accordance with the ICH Guidelines. Starting from development of new methods followed by validation and stability testing our customers can choose between full testing packages and individual analyses.
For characterisation of biopharmaceuticals we analyse various testing parameters:
- Identity (e.g. N- and C-terminal sequencing, peptide mapping, carbohydrate analysis)
- Physicochemical attributes (e.g. water content, osmolality, visible particles)
- Purity (e.g. SEC, SDS-PAGE, CGE, CIEF)
- Impurity (e.g. HCP ELISA, residual DNA)
- Content (e.g. ELISA, RP-HPLC)
- Biological activity (bioassay)